Clinical Trial Update: Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating glofitamab in mantle cell lymphoma patients whose disease returned after CAR-T therapy, and the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma | Phase 2 | Status: RECRUITING